During the past decade, Clinica de Investigacion en Reumatologia y Obesidad S. C. conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 13 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica de Investigacion en Reumatologia y Obesidad S. C." #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica de Investigacion en Reumatologia y Obesidad S. C." #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Clinica de Investigacion en Reumatologia y Obesidad S. C." are "Rheumatoid Arthritis" (8 trials), "Systemic Lupus Erythematosus" (5 trials), "Juvenile Idiopathic Arthritis" (2 trials), "Alopecia Areata" (1 trials) and "Arthritis" (1 trials). Many other conditions were trialed in "Clinica de Investigacion en Reumatologia y Obesidad S. C." in a lesser frequency.

Most popular intervention types in "Clinica de Investigacion en Reumatologia y Obesidad S. C." are "Drug" (23 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (4 trials), "Methotrexate" (2 trials), "Abatacept" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica de Investigacion en Reumatologia y Obesidad S. C." are 23 trials for "All" genders.

Currently, there are NaN active trials in "Clinica de Investigacion en Reumatologia y Obesidad S. C.". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Clinica de Investigacion en Reumatologia y Obesidad S. C., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica de Investigacion en Reumatologia y Obesidad S. C., 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Clinica de Investigacion en Reumatologia y Obesidad S. C. has several departments that took part in Clinical trials: "Clinica de Investigacion en Reumatologia y Obesidad" - 2 trials